Published in J Clin Endocrinol Metab on December 01, 1993
Protein and amino acid restriction, aging and disease: from yeast to humans. Trends Endocrinol Metab (2014) 0.97
Insulin-like growth factor I response during nutritional rehabilitation of persistent diarrhoea. Arch Dis Child (1999) 0.86
IGFBP-2 - taking the lead in growth, metabolism and cancer. J Cell Commun Signal (2015) 0.84
Acute illness is associated with suppression of the growth hormone axis in Zimbabwean infants. Am J Trop Med Hyg (2014) 0.83
Early life height and weight production functions with endogenous energy and protein inputs. Econ Hum Biol (2016) 0.82
The insulin-like growth factor system and nutritional assessment. Scientifica (Cairo) (2012) 0.80
Radioiodine therapy versus antithyroid drugs in Graves' disease: a meta-analysis of randomized controlled trials. Br J Radiol (2016) 0.78
Control of IGFBP-2 Expression by Steroids and Peptide Hormones in Vertebrates. Front Endocrinol (Lausanne) (2014) 0.77
Insulin Growth Factor 1 Protects Neural Stem Cells Against Apoptosis Induced by Hypoxia Through Akt/Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase (Akt/MAPK/ERK) Pathway in Hypoxia-Ishchemic Encephalopathy. Med Sci Monit (2017) 0.75
Early Elevation in Interleukin-6 is Associated with Reduced Growth in Extremely Low Birth Weight Infants. Am J Perinatol (2016) 0.75
Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev (1995) 9.54
Nutritional rickets in African American breast-fed infants. J Pediatr (2000) 4.76
Effect of community-based peer counsellors on exclusive breastfeeding practices in Dhaka, Bangladesh: a randomised controlled trial [see commments]. Lancet (2000) 4.67
Unidentified gram-negative rod infection. A new disease of man. Ann Intern Med (1977) 3.53
Nutritional regulation of the insulin-like growth factors. Endocr Rev (1994) 3.18
Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci U S A (1984) 3.13
Sharing of virulence-associated properties at the phenotypic and genetic levels between enteropathogenic Escherichia coli and Hafnia alvei. J Med Microbiol (1992) 3.03
Delayed diagnoses of Turner's syndrome: proposed guidelines for change. J Pediatr (2000) 2.95
Clinical uses of insulin-like growth factor I. Ann Intern Med (1994) 2.93
Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest (1977) 2.46
A MEASURE-THEORETIC COMPUTATIONAL METHOD FOR INVERSE SENSITIVITY PROBLEMS I: METHOD AND ANALYSIS. SIAM J Numer Anal (2011) 2.27
Chloramphenicol-resistant typhoid fever in Vietnam associated with R factor. Lancet (1973) 2.25
Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. J Clin Endocrinol Metab (1998) 2.17
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med (2000) 2.16
Prolactin-dependent rat mammary cancer: a model for man? Trans Assoc Am Physicians (1969) 2.15
Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev Biol (1996) 2.15
Evidence that somatomedin is synthesized by multiple tissues in the fetus. Dev Biol (1980) 2.11
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet (2001) 2.08
Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice. Endocrinology (2008) 2.03
Mechanisms of glucocorticoid-induced myopathy. J Endocrinol (2008) 1.94
Hormonal control of immunoreactive somatomedin production by cultured human fibroblasts. J Clin Invest (1981) 1.92
Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients. Crit Care Med (2001) 1.88
Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci U S A (1993) 1.85
Behavior change after growth hormone treatment of children with short stature. J Pediatr (1998) 1.82
The somatomedins: a family of insulinlike hormones under growth hormone control. Recent Prog Horm Res (1974) 1.76
Mortality among homeless people with schizophrenia in Sydney, Australia: a 10-year follow-up. Acta Psychiatr Scand (2001) 1.68
Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. Endocrinology (1998) 1.66
Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J Cell Biol (1993) 1.64
An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci U S A (1987) 1.57
Risk factors for development of hemolytic uremic syndrome during shigellosis. J Pediatr (1987) 1.53
Shigella septicemia: prevalence, presentation, risk factors, and outcome. J Infect Dis (1985) 1.52
Typhoid fever. Studies of blood coagulation, bacteremia, and endotoxemia. Arch Intern Med (1978) 1.52
Explorations of the insulinlike and growth-promoting properties of somatomedin by membrane receptor assays. Adv Metab Disord (1975) 1.49
Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes (1996) 1.49
Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy. Endocrinology (2006) 1.49
Induction of immunoreactive somatomedin C human serum by growth hormone: dose-response relationships and effect on chromatographic profiles. J Clin Endocrinol Metab (1980) 1.48
Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults. J Clin Endocrinol Metab (1995) 1.47
Patterns of morbidity and mortality in typhoid fever dependent on age and gender: review of 552 hospitalized patients with diarrhea. Rev Infect Dis (1991) 1.47
Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor. Proc Natl Acad Sci U S A (1996) 1.46
Septicemia caused by Capnocytophaga in a granulocytopenic patient with glossitis. Arch Intern Med (1980) 1.44
The insulin-like growth factors. Annu Rev Physiol (1993) 1.44
Typhoid fever complicated by intestinal perforation: a persisting fatal disease requiring surgical management. Rev Infect Dis (1985) 1.44
Evidence for a functional role of endogenously produced somatomedinlike peptides in the regulation of DNA synthesis in cultured human fibroblasts and porcine smooth muscle cells. J Clin Invest (1985) 1.43
Distribution and spread of colonic lesions in shigellosis: a colonoscopic study. J Infect Dis (1984) 1.42
Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study. Crit Care Med (2001) 1.41
The acidosis of cholera. Contributions of hyperproteinemia, lactic acidemia, and hyperphosphatemia to an increased serum anion gap. N Engl J Med (1986) 1.40
Stimulation of statural growth by recombinant insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron type) J Pediatr (1992) 1.37
Zinc supplementation increases growth and circulating insulin-like growth factor I (IGF-I) in growth-retarded Vietnamese children. Am J Clin Nutr (1996) 1.36
Activation of protein mediators of inflammation and evidence for endotoxemia in Borrelia recurrentis infection. Am J Med (1977) 1.34
Academic achievement and psychological adjustment in short children. The National Cooperative Growth Study. J Dev Behav Pediatr (1994) 1.34
Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother (1999) 1.33
Blocking ligand occupancy of the alphaVbeta3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells. Proc Natl Acad Sci U S A (1998) 1.32
Glucocorticoid-induced skeletal muscle atrophy. Int J Biochem Cell Biol (2013) 1.32
Evidence from radioligand assays that somatomedin-C and insulin-like growth factor-I are similar to each other and different from other somatomedins. J Clin Endocrinol Metab (1980) 1.31
The global atmospheric environment for the next generation. Environ Sci Technol (2006) 1.30
MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials. Aliment Pharmacol Ther (2007) 1.28
Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C/insulinlike growth factor I. J Clin Invest (1986) 1.27
Yersinia pestis infection in Vietnam. II. Quantiative blood cultures and detection of endotoxin in the cerebrospinal fluid of patients with meningitis. J Infect Dis (1976) 1.26
Neonatal and infantile hypoglycemia due to insulin excess: new aspects of diagnosis and surgical management. Ann Surg (1977) 1.26
Involvement of STAT5 (signal transducer and activator of transcription 5) and HNF-4 (hepatocyte nuclear factor 4) in the transcriptional control of the hnf6 gene by growth hormone. Mol Endocrinol (2000) 1.26
Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients. J Clin Endocrinol Metab (1993) 1.26
The use of oral replacement solutions in the treatment of choleraand other severe diarrhoeal disorders. Bull World Health Organ (1970) 1.25
Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth. Endocrinology (2000) 1.25
Randomized treatment of patients with typhoid fever by using ceftriaxone or chloramphenicol. J Infect Dis (1988) 1.24
Leprechaunism: studies of the relationship among hyperinsulinism, insulin resistance, and growth retardation. J Clin Endocrinol Metab (1979) 1.23
Characterization of the insulin and somatomedin-C receptors in human placental cell membranes. J Clin Endocrinol Metab (1974) 1.22
Insulin-like growth factor (IGF)-binding proteins inhibit the smooth muscle cell migration responses to IGF-I and IGF-II. Endocrinology (1995) 1.20
Insulin-like growth factors (IGF) in muscle development. Expression of IGF-I, the IGF-I receptor, and an IGF binding protein during myoblast differentiation. J Biol Chem (1989) 1.20
Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyriboncleic acid synthesis by insulin-like growth factor-I. Endocrinology (1999) 1.19
Hormonal and nutritional regulation of IGF-I and its binding proteins. Horm Res (1994) 1.18
Competitive binding of somatomedin to the insulin receptors of adipocytes, chondrocytes, and liver membranes. Proc Natl Acad Sci U S A (1972) 1.18
Nutritional regulation of IGF-I and IGF binding proteins. Annu Rev Nutr (1991) 1.17
Cell migration: interactions among integrins, IGFs and IGFBPs. Prog Growth Factor Res (1995) 1.16
Oral health status of prison inmates--New South Wales, Australia. Aust Dent J (2003) 1.16
Dietary components that regulate serum somatomedin-C concentrations in humans. J Clin Invest (1983) 1.16
Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. Proc Natl Acad Sci U S A (1991) 1.15
Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae. J Infect Dis (1987) 1.15
Does the GH-IGF axis play a role in cancer pathogenesis? Growth Horm IGF Res (2000) 1.14
Cloning, characterization, and expression of a human insulin-like growth factor binding protein. Biochem Biophys Res Commun (1988) 1.14
The use of solid-phase radioimmunoassay techniques for serodiagnosis of human plague infection. Bull Pan Am Health Organ (1980) 1.13
A highly conserved insulin-like growth factor-binding protein (IGFBP-5) is expressed during myoblast differentiation. J Biol Chem (1993) 1.13
Acute lower respiratory tract infection due to virus among hospitalized children in Dhaka, Bangladesh. Rev Infect Dis (1991) 1.13
Multiple hormones stimulate the production of somatomedin by cultured human fibroblasts. J Clin Endocrinol Metab (1984) 1.13
Evaluation of acromegaly by radioimmunoassay of somatomedin-C. N Engl J Med (1979) 1.13
Regulation of insulin-like growth factor-I in starvation and injury. Nutr Rev (1999) 1.12
Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions. J Biol Chem (2000) 1.12
Role of Akt/GSK-3beta/beta-catenin transduction pathway in the muscle anti-atrophy action of insulin-like growth factor-I in glucocorticoid-treated rats. Endocrinology (2008) 1.11
Individual traits and family contexts predict sons' externalizing behavior and preliminary relative risk ratios for conduct disorder and substance use disorder outcomes. Drug Alcohol Depend (1999) 1.11
Growth hormone levels during sleep in normal and growth hormone deficient children. Pediatrics (1971) 1.11